Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Beltran and colleagues discuss the challenges in treating metastatic prostate cancer and strategies to accelerate precision oncology and improve therapy and clinical decisions in this setting.
Aguirre-Ghiso and colleagues discuss the current status of the cancer dormancy field, including challenges and opportunities for monitoring and targeting dormant cancer.
Bozic and Wu discuss how quantitative mathematical models elucidate the various stages of tumor evolution, from premalignancy to malignant progression, and the response to therapy.
